These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 28476437)

  • 1. Sjogren's syndrome from the perspective of ophthalmology.
    Kuklinski E; Asbell PA
    Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
    Ogawa Y
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
    Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different perception of dry eye symptoms between patients with and without primary Sjogren's syndrome.
    Kim M; Chun YS; Kim KW
    Sci Rep; 2022 Feb; 12(1):2172. PubMed ID: 35140286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
    Ramos-Casals M; Brito-Zerón P; Bombardieri S; Bootsma H; De Vita S; Dörner T; Fisher BA; Gottenberg JE; Hernandez-Molina G; Kocher A; Kostov B; Kruize AA; Mandl T; Ng WF; Retamozo S; Seror R; Shoenfeld Y; Sisó-Almirall A; Tzioufas AG; Vitali C; Bowman S; Mariette X;
    Ann Rheum Dis; 2020 Jan; 79(1):3-18. PubMed ID: 31672775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry eye in Sjögren's syndrome - characteristics and therapy.
    Caban M; Omulecki W; Latecka-Krajewska B
    Eur J Ophthalmol; 2022 Nov; 32(6):3174-3184. PubMed ID: 35354331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
    Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
    Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
    Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
    PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
    Nishinarita M; Hanzawa M; Iikuni N; Ota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):99-102. PubMed ID: 15164930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome.
    Gao M; Zhao L; Liang R; Zhu Q; Zhao Q; Kong X
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1662-1668. PubMed ID: 35914303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Pathophysiology of Sjögren's Syndrome.
    Tauqeer Z; Bunya VY; Macchi I; Massaro-Giordano M
    Ocul Immunol Inflamm; 2021 May; 29(4):796-802. PubMed ID: 33830848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflex tearing in dry eye not associated with Sjögren's syndrome.
    Tsubota K
    Adv Exp Med Biol; 1998; 438():903-7. PubMed ID: 9634986
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.